Clinical Trials Directory

Trials / Completed

CompletedNCT06043544

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis: a Monocentric Randomized Open-label Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Concordia Hospital Rome · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This monocentric randomized open-label study aims to assess the efficacy and safety of a treatment with medium molecular weight hyaluronic acid (HA) compared to a treatment with corticosteroids on patients affected by glenohumeral osteoarthritis.

Detailed description

Glenohumeral osteoarthritis (OA) is a very common joint disease characterized by pain and functional limitation. No standardized protocols of treatment are available in clinical practice and literature data are confusing. This monocentric randomized open-label study aims to assess the efficacy and safety of a treatment with medium molecular weight hyaluronic acid (HA) compared to a treatment with corticosteroids on patients affected by glenohumeral osteoarthritis. A total of 80 consecutive patients with glenohumeral OA (Kellegren Lawrence degree II or III) were randomized in two different groups, intto Hymovis® (24mg/3ml) (treatment group) or into corticosteroids (control group), with a follow-up after 3 and 6 months. Modifications in terms of pain (VAS), range of motion (ROM) and quality of life (EQ-5D) were observed during the treatment.

Conditions

Interventions

TypeNameDescription
DEVICEHyaluronic Acid 24 MG in 3 mL Prefilled SyringePatients in the treatment group received two intra-articular injections with Hymovis® (24mg/3ml) a week apart from each other
DRUGCorticosteroid injectionPatients in control group received two intra-articular injections with corticosteroids a week apart from each other.

Timeline

Start date
2021-05-02
Primary completion
2021-11-10
Completion
2022-03-31
First posted
2023-09-21
Last updated
2023-09-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06043544. Inclusion in this directory is not an endorsement.